Venentoclax Clinical Trials in Zhengzhou, Henan
2 recruitingZhengzhou, Henan, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
VenentoclaxALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONMyeloid Malignancies+3 more
First Affiliated Hospital of Zhejiang University186 enrolled18 locationsNCT07396480
Recruiting
Not Applicable
The Maintenance Treatment of "ITIVA" in AML Patients
Acute Myeloid LeukemiaMaintenance TreatmentMinor Residue Disease+5 more
Henan Cancer Hospital130 enrolled1 locationNCT06256627